Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Clinical trial NCT03594045 · TERMINATED

Trial details

NCT number: NCT03594045
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Heparin-induced Thrombocytopenia Heparin-induced Thrombocytopenia and Thrombosis

Start date: 2018-12-18
Primary completion: 2019-10-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.